arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2201.07263cs.CY
收藏

Facebook上的健康广告:隐私和政策考虑

Health Advertising on Facebook: Privacy & Policy Considerations

Andrea Downing, Eric Perakslis

摘要:

在这项研究中,我们分析了数字医药公司的内容和营销策略,以评估各种类型的跨站点跟踪中间件,用于在未经许可的情况下从用户那里提取健康信息。更具体地说,我们研究了如何在数字医药公司和Facebook之间交换浏览数据,以用于广告和潜在客户开发。该分析的重点是一个小型生态系统的公司提供服务的患者在癌症社区,经常参与社交媒体。我们的内容分析中的一些公司可能符合联邦贸易委员会所涵盖的个人健康记录供应商的法律定义,其他公司则是HIPAA涵盖的实体。我们的分析结果提出了关于什么构成违反联邦贸易委员会的健康违规通知规则的政策问题。几个例子表明了隐私实践不一致的严重问题,并揭示了数字医学暗模式如何从患者和提供广告的公司那里获取未经授权的数据。此外,我们还讨论了这些常见的营销实践如何使医疗广告的监测和针对弱势患者群体,这可能是不明显的公司瞄准广告。

英文摘要:

In this study we analyzed content and marketing tactics of digital medicine companies to evaluate various types of cross site tracking middleware used to extract health information from users without permission. More specifically we examine how browsing data can be exchanged between digital medicine companies and Facebook for advertising and lead generation purposes. The analysis was focused on a small ecosystem of companies offering services to patients within the cancer community that frequently engage on social media. Some companies in our content analysis may fit the legal definition of a personal health record vendor covered by the Federal Trade Commission, others are HIPAA covered entities. The findings of our analysis raise policy questions about what constitutes a breach under the Federal trade Commission's Health Breach Notification Rule. Several examples demonstrate serious problems with inconsistent privacy practices and reveal how digital medicine dark patterns may elicit unauthorized data from patients and companies serving ads. Further we discuss how these common marketing practices enable surveillance and targeting of medical ads to vulnerable patient populations, which may not be apparent to the companies targeting ads.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑